Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease

Lancet. 1995 Jun 3;345(8962):1445. doi: 10.1016/s0140-6736(95)92635-6.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Colitis / drug therapy*
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Male
  • Pentoxifylline / pharmacology
  • Pentoxifylline / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Tumor Necrosis Factor-alpha
  • Pentoxifylline